Skip to main content
|
Interne |
Passing Juice |
Dr Sikhulile Moyo named to TIME's annual TIME100 list of the 100 most influential people in the world
|
Interne |
Passing Juice |
Dr Sikhulile Moyo named to TIME's annual TIME100 list of the 100 most influenti…
|
Interne |
noFollow |
Botswana Harvard AIDS Institute Partnership launchs new website.
|
Interne |
Passing Juice |
Home
|
Interne |
Passing Juice |
Who We Are
|
Interne |
Passing Juice |
History
|
Interne |
Passing Juice |
Board of Members
|
Interne |
Passing Juice |
Board of Directors
|
Interne |
Passing Juice |
Executive Management
|
Interne |
Passing Juice |
Senior Management
|
Interne |
Passing Juice |
Principal Investigators
|
Interne |
Passing Juice |
Our Capacity
|
Interne |
Passing Juice |
Partners
|
Interne |
Passing Juice |
Collaborators
|
Interne |
Passing Juice |
Sponsors
|
Interne |
Passing Juice |
Careers
|
Interne |
Passing Juice |
Tenders
|
Interne |
Passing Juice |
Research Themes
|
Interne |
Passing Juice |
Studies
|
Interne |
Passing Juice |
Ongoing Studies
|
Interne |
Passing Juice |
Completed Studies
|
Interne |
Passing Juice |
Laboratory
|
Interne |
Passing Juice |
Pharmacy
|
Interne |
Passing Juice |
Clinical Research Sites
|
Interne |
Passing Juice |
Data Management
|
Interne |
Passing Juice |
Regulatory
|
Interne |
Passing Juice |
Publications
|
Interne |
Passing Juice |
Training
|
Interne |
Passing Juice |
Projects
|
Interne |
Passing Juice |
Community Engagement Activities
|
Interne |
Passing Juice |
Community Advisory Boards
|
Interne |
Passing Juice |
Media
|
Interne |
Passing Juice |
News
|
Interne |
Passing Juice |
Newsletters
|
Interne |
Passing Juice |
Press Releases
|
Interne |
Passing Juice |
Annual Reports
|
Interne |
Passing Juice |
Donate
|
Interne |
Passing Juice |
Find Out More
|
Externe |
noFollow |
Find Out More
|
Interne |
noFollow |
HPTN 084: A Phase 3 Double Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women
|
Interne |
Passing Juice |
HVTN 703/HPTN 081 (AMP Study): A phase 2b study to evaluate the efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in Sub- Saharan Africa.
|
Interne |
Passing Juice |
HVTN805/HPTN093: Antiretroviral analytical treatment interruption (ATI) to assess immunologic and virologic responses in participants who initiated ART in early HIV infection after having received VRC01 or placebo in HVTN 703/HPTN 081.
|
Interne |
Passing Juice |
REPRIEVE (A5332): A randomized trial to prevent vascular events (such as stroke and heart attack) in people living with HIV.
|
Interne |
Passing Juice |
Potlako: A programmatic Multi-Facility Level Intervention to Improve Access to timely Oncology Care in Botswana
|
Interne |
Passing Juice |
PHOENIx (A5300B): Protecting Households on Exposure to Newly Diagnosed Index Multidrug Resistant TB patients
|
Interne |
Passing Juice |
IMPAACT 2019 – Phase I/II Study of the Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less than 12 Years of Age
|
Interne |
Passing Juice |
P1093 - Phase I/II, Multi-Centre, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and Adolescents
|
Interne |
Passing Juice |
IMPAACT 2005
|
Interne |
Passing Juice |
IMPAACT 2017 - Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed HIV-Infected Children and Adolescents
|
Interne |
Passing Juice |
CoVPN 5001: A Prospective Study of Acute Immune Responses to SARS-CoV-2 Infection.
|
Interne |
Passing Juice |
Birth Outcomes Surveillance Study: Tsepamo Study
|
Interne |
Passing Juice |
Early Infant Treatment Study: A Clinical Trial of HIV Positive Infants in Botswana
|
Interne |
Passing Juice |
Tshilo Dikotla Study: Metabolic Outcomes of Children HIV/ARV- Exposed Uninfected in Botswana
|
Interne |
Passing Juice |
Karabo Study: Immune Correlates of Tuberculosis and non-Tuberculosis Infectious Morbidity in Southern African HIV- Exposed, Uninfected Infants
|
Interne |
Passing Juice |
FLOURISH: Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health for Infants, Children, Adolescents who are HIV Exposed Uninfected
|
Interne |
Passing Juice |
Feasibility and Accuracy of Nanosenor-based cancer diagnosis at the point of care (Chedza Study).
|
Interne |
Passing Juice |
Characterization of Anthracycline induced Cardiotoxicity Using Cardiac Magnetic Resonance in Botswana: A Prospective Observational study (Pelo Study)
|
Interne |
Passing Juice |
HIV and Malignancy in Botswana: An observational Study of Medicine Toxicity of Concurrent Treatment and Clinical Outcomes (Thabatse Study)
|
Interne |
Passing Juice |
Potlako+ : A multilevel intervention to improve timely cancer detection and treatment initiation in Botswana
|
Interne |
Passing Juice |
Human Papillomavirus (HPV) Cervical Cancer Screening Study
|
Interne |
Passing Juice |
The diagnosis and treatment of Chlamydia Trachomatis and Neisseria Gonorrhea in Woman to prevent adverse neonatal consequences (Maduo/STI Study)
|
Interne |
Passing Juice |
Contraceptives and Dolutegravir-based ART (CODA) Study
|
Interne |
Passing Juice |
Albuminuria Among Virally Suppressed HIV-infected Patients in Botswana: Longitudinal Changes and Association with Inflammation and ACEI/ARB Use in a Clinical Setting - Albuminuria Study
|
Interne |
Passing Juice |
Mopati: A Pilot HIV Treatment Partner Intervention in Botswana
|
Interne |
Passing Juice |
Exploring the Acceptability and Feasibility of COVID19 Testing among Truck Drivers in Botswana
|
Interne |
Passing Juice |
Innovative HIV Testing Strategy for Middle-to-Upper Income Men in a Resource-Limited Setting
|
Interne |
Passing Juice |
Integrating Hypertension and Cardiovascular Diseases Care into Existing HIV Services Package in Botswana (InterCARE Study)
|
Interne |
Passing Juice |
Prevalence and outcomes of the usage of lumbar puncture in patients who presented with central nervous system symptoms at Princess Marina Hospital during the period 01/01/2014 to 31/03/2021
|
Interne |
Passing Juice |
A cross-sectional evaluation of antibody responses to SARS-COV-2 vaccines
|
Interne |
Passing Juice |
Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern: CoVPN 3008
|
Interne |
Passing Juice |
Mitigating the impact of COVID-19 effects in adolescent reproductive health through self-testing: a mixed methods pilot study: “ICHEKE”
|
Interne |
Passing Juice |
International Sexual Health and Reproductive (ISHARE) Health Survey During COVID-19
|
Interne |
Passing Juice |
Assessment of proviral reservoir: synergistic combination of reporter cell assay and viral diversity
|
Interne |
Passing Juice |
Understanding the Mechanisms of Adverse Birth Outcomes in Botswana
|
Interne |
Passing Juice |
SOLIDARITY Trial: An international (multisite)randomized trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care
|
Interne |
Passing Juice |
Open-label access to dolutegravir for HIV-1 infected children and adolescents completing IMPAACT Studies P1093 and P2019: GSK205858
|
Interne |
Passing Juice |
Assessing barriers and facilitators to improving prenatal supplementation and preconception fortification in Botswana – a qualitative study
|
Interne |
Passing Juice |
COVID-19: An observational cohort of cases treated in Gaborone, Botswana
|
Interne |
Passing Juice |
Botswana Combination Prevention Project (BCPP) / Ya Tsie Study
|
Interne |
Passing Juice |
IMPAACT 2008: A Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants
|
Interne |
Passing Juice |
IMPAACT 2010: IMPAACT 2010 Phase III Study of the Virologic Efficacy and Safety of Dolutegravir-Containing versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and their Infants
|
Interne |
Passing Juice |
IMPAACT P1026s: Pharmacokinetic Properties of Antiretroviral And Related Drugs During Pregnancy And Postpartum
|
Interne |
Passing Juice |
Effects of preterm birth on HIV acquisition risk and antiretroviral prophylaxis in HIV-exposed infants in Botswana (PERHAPS)
|
Interne |
Passing Juice |
The AMBIsome Therapy Induction OptimisatioN (AMBITION-cm)
|
Interne |
Passing Juice |
Assessing the potential role of a novel hand-held device (the Intelligent Breast Exam), in breast cancer screening in Botswana: A feasibility pilot study
|
Interne |
Passing Juice |
Kgothatso: Male cancer care barriers in Botswana
|
Interne |
Passing Juice |
Innovating to save lives: Evaluation of breast cancer care and outcomes in the setting of Breast multidisciplinary clinic in Botswana (Maduo Study)
|
Interne |
Passing Juice |
Acceptability and uptake of HIV self-testing among female sex workers in Botswana: Ikitse Study
|
Interne |
Passing Juice |
Botswana COVID-19 Active Case Finding Pilot Study and Demonstration Project
|
Interne |
Passing Juice |
The Lived Experience of Participants in COVID-19 Clinical Studies in Gaborone– World Health Organisation (WHO)
|
Interne |
Passing Juice |
A5375: An Open-Label, Phase II Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination with Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy
|
Interne |
Passing Juice |
Optimizing Maternal & Child Health and Development (Monana Ke Isago Study)
|
Interne |
Passing Juice |
A Clinical Trial to Evaluate the Impact of Broadly Neutralizing Antibodies VRC01LS and 10-1074 on Maintenance of HIV Suppression in a Cohort of Early-Treated Children in Botswana (Dual bNAb Treatment in Children)/ Tatelo Study
|
Interne |
Passing Juice |
Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir or Efavirenz and HIV-Unexposed Children (Motheo Study)
|
Interne |
Passing Juice |
A Randomized Study of Cotrimoxazole Prophylaxis and Longer Breastfeeding Duration to Improve Survival Among HIV-Exposed Infants in Botswana ("Mpepu")
|
Interne |
Passing Juice |
Prevention of Milk-Borne Transmission of HIV-1 in Botswana (“Mashi”)
|
Interne |
Passing Juice |
Virologic Response to NVP-Containing HAART after Single-DoseNVP vs.Placebo (“Mashi Plus”)
|
Interne |
Passing Juice |
Randomized Trial of LPV/r/ZDV3TC vs. ABC/ZDV/3TC to Prevent MTCT in Pregnant/Breastfeeding Women with CD4>200 (“MmaBana”)
|
Interne |
Passing Juice |
Effects of HIV and ARV Exposure on Child Health and Neurodevelopment, Botswana (“Tshipidi”)
|
Interne |
Passing Juice |
Post-acute sequelae of SARS-CoV-2 infection (PASC) / ‘Long Covid’: observational cohort: “Motlhala” Study
|
Interne |
Passing Juice |
Open-Label, Single-Arm, Phase 3B Study of the Incidence of Severe COVID-19 and Adverse Events Following AZD1222 COVID-19 Vaccination in Botswana Against SARS-CoV-2
|
Interne |
Passing Juice |
Dr Sikhulile Moyo wins the German Africa Award
|
Interne |
Passing Juice |
BHP Courtesy meeting with UB Vice Chancellor & Professor Karim
|
Interne |
Passing Juice |
BOTSOGO celebrates 10th Anniversary
|
Interne |
Passing Juice |
BHP improves conditions of service
|
Interne |
Passing Juice |
f
|
Externe |
noFollow |
t
|
Externe |
noFollow |
l
|
Externe |
noFollow |
y
|
Externe |
noFollow |
Contact Us
|
Interne |
Passing Juice |
Website Design and Development - MindQ
|
Externe |
Passing Juice |